China Cord Blood Corporation
 (CO)

- NYSE
What's your position on ?
Bullish
Bearish
Why are you ish?
Skip
Post
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Last vote:
  • Nov. 24, 2015, 7:50 AM
    • China Cord Blood (CO +0.8%) FQ2 results (NYSEARCA:RMB): Revenues: 171.5M (+12.8%); R&D Expense: 2.2M (-4.3%); SG&A: 79.6M (+28.4%); Operating Income: 52.5M (-8.7%); Net Income: 18.7M (-31.3%); EPS: 0.25 (-28.6%); Quick Assets: 2,436.7M (-8.8%).
    • No guidance given.
    | Nov. 24, 2015, 7:50 AM
  • Nov. 23, 2015, 4:21 PM
    • China Cord Blood (NYSE:CO): FQ2 EPS of $0.04 in-line.
    • Revenue of $26.98M (+8.9% Y/Y) beats by $0.56M.
    • Press Release
    | Nov. 23, 2015, 4:21 PM
  • Aug. 20, 2015, 8:00 AM
    • China Cord Blood (CO -2.1%) FQ1 results (NYSEARCA:RMB): Revenues: 165.4M (+7.9%); Gross Profit: 128.8M (+4.2%); Operating Expenses: 80.4M (+26.8%); Operating Income: 48.4M (-19.6%); Net Income: 13.6M (-54.2%); EPS: 0.19 (-48.6%); Quick Assets: 2,560.9M (+5.1%); CF Ops: 130.1M (+4.4%).
    • No guidance given.
    | Aug. 20, 2015, 8:00 AM
  • Aug. 19, 2015, 4:06 PM
    • China Cord Blood (NYSE:CO): FQ1 EPS of $0.03 misses by $0.01.
    • Revenue of $26.7M (+8.0% Y/Y) beats by $0.89M.
    | Aug. 19, 2015, 4:06 PM | 1 Comment
  • Jun. 18, 2015, 4:45 PM
    • China Cord Blood (NYSE:CO) fiscal Q4 results ($M): Revenues: 26.3 (+7.3%); Operating Income: 8.0 (-22.7%); Net Income: 2.7 (-57.2%); CF Ops: 23.6 (+6.6%).
    • New subscribers: 15,982; Accumulated subscriber base: 441,359.
    • The company will host its conference call tomorrow morning at 8:00 am ET.
    • Shares are up 3% after hours on light volume.
    | Jun. 18, 2015, 4:45 PM
  • Jun. 18, 2015, 4:03 PM
    • China Cord Blood (NYSE:CO): FQ4 EPS of $0.04 misses by $0.01.
    • Revenue of $26.3M (+7.6% Y/Y) beats by $0.42M.
    | Jun. 18, 2015, 4:03 PM
  • Jun. 17, 2015, 1:30 PM
    • China Cord Blood (CO +5.3%) breaks out of consolidation on a 5x surge in volume. No particular news accounts for the move other than tomorrow's earnings announcement after the close. Consensus views for fiscal Q4 and fiscal 2015 are EPS of $0.05 (-28.6%) and $0.24 on revenues of $25.9M (+6.1%) and $103.3M, respectively.
    • The conference call will start at 8:00 am ET on Friday, June 19.
    | Jun. 17, 2015, 1:30 PM
  • Feb. 25, 2015, 4:35 PM
    • China Cord Blood (NYSE:CO): FQ3 EPS of $0.07 beats by $0.01.
    • Revenue of $26.86M (+8.0% Y/Y) beats by $0.51M.
    | Feb. 25, 2015, 4:35 PM
  • Nov. 26, 2014, 7:24 AM
    • China Cord Blood Corp. (CO +2.8%) FQ2 results (NYSEARCA:RMB): Revenues: 152.1M (+7.4%); Gross Profit: 121.8M (+6.6%); Operating Income: 57.5M (+2.1%); Net Income: 27.2M (+9.2%); EPS: 0.35 (+6.1%); Quick Assets: 2,156.5M (14.5%); CF Ops: 171M (+41.3%).
    • No guidance given.
    | Nov. 26, 2014, 7:24 AM
  • Nov. 25, 2014, 4:19 PM
    • China Cord Blood (NYSE:CO): FQ2 EPS of $0.06 in-line.
    • Revenue of $24.78M (+7.1% Y/Y) misses by $1.04M.
    | Nov. 25, 2014, 4:19 PM
  • Aug. 28, 2014, 4:35 PM
    • China Cord Blood Corp. (CO -1.3%) fiscal Q1 results (RMB): Revenues: 153.3M (+19.1%); Gross Profit: 123.6M (+18.6%); Operating Expenses: 63.4M (+8.7%); Operating Income: 60.2M (+31.2%);  Net Income: 29.7M (-10.1%); EPS: 0.37 (-7.5%); Quick Assets: 1,989.5M (+5.7%); CF Ops: 124.6M.
    • No financial guidance given.
    | Aug. 28, 2014, 4:35 PM
  • Aug. 28, 2014, 4:21 PM
    • China Cord Blood (NYSE:CO): FQ1 EPS of $0.06 beats by $0.01.
    • Revenue of $24.71M (+18.0% Y/Y) in-line.
    | Aug. 28, 2014, 4:21 PM
  • Jun. 18, 2014, 4:33 PM
    • China Cord Blood (CO +2.8%) Q4 results: revenues: RMB151.9M (+14.2%); gross profit: RMB124.6M (+17.4%); net income: RMB39.5M (+71.7%); CF Ops: RMB137.4M.
    • FY14: revenues: RMB572.9M (+8.9%); gross profit: RMB466.6M (+11.2%); net income: RMB131.9M (+17.3%); CF Ops: RMB536.0M; cash & equivalents as of March 31: RMB1.5B.
    | Jun. 18, 2014, 4:33 PM
  • Jun. 18, 2014, 4:11 PM
    • China Cord Blood (CO): FQ4 EPS of $0.07 beats by $0.01.
    • Revenue of $24.43M (+14.1% Y/Y) misses by $0.34M.
    | Jun. 18, 2014, 4:11 PM
  • Feb. 24, 2014, 4:51 PM
    • China Cord Blood Corporation (CO): FQ3 EPS of $0.07 beats by $0.01.
    • Revenue of $24.9M (+3.9% Y/Y) beats by $0.68M.
    | Feb. 24, 2014, 4:51 PM
Company Description
China Cord Blood Corp provides cord blood banking services. The Company provides cord blood processing and storage services for expectant parents interested in capturing the evolving medical treatments & technologies such as cord blood transplants.